CFDE Data Portal | Search NKX6-3

	Label	Description
	NKX6-3 associations Collection (Entity type)	Associations for NKX6-3_associations
	NKX6-3 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	NKX6-3 Gene (Entity type)	ENSG00000165066 - NK6 homeobox 3
	KFGENEBIN:NKX6-3-variant-count CUI gene has variants NKX6-3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Kids First
	GSE102505 5 V 0 TUNICAMYCIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE240439 decitabine 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE128730 3 V 5 NERATINIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE172016 2 V 0 PACLITAXEL HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE135350 3 V 5 DEXAMETHASONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE195568 palbociclib 2 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS

NKX6-3 associations

Associations for NKX6-3_associations

NKX6-3 associations.tsv

A file from IDG as part of the Harmonizome project

NKX6-3

ENSG00000165066 - NK6 homeobox 3

KFGENEBIN:NKX6-3-variant-count CUI gene has variants NKX6-3

A Knowledge Graph Assertion from Kids First

GSE102505 5 V 0 TUNICAMYCIN HUMAN DN

A Gene Set from LINCS

GSE240439 decitabine 1 v 2 human up

A Gene Set from LINCS

GSE128730 3 V 5 NERATINIB HUMAN UP

A Gene Set from LINCS

GSE172016 2 V 0 PACLITAXEL HUMAN DN

A Gene Set from LINCS

GSE135350 3 V 5 DEXAMETHASONE HUMAN UP

A Gene Set from LINCS

GSE195568 palbociclib 2 v 10 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.